Neoadjuvant Chemotherapy for Obstructive Colon cancER first Treated by cOlostomy : A randomized phase III trial - COnCERTO (French 01-18) 2019/0407/HP

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516456-17-00

Acronym

2019/0407/HP

Enrollment

232

Registered

2024-09-26

Start date

2024-05-07

Completion date

Unknown

Last updated

2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients admitted for an obstructive colon cancer

Brief summary

the success of a full curative therapeutic

Interventions

DRUGOXALIPLATIN

DRUGELOXATINE 5 mg/ml

DRUGsolution à diluer pour perfusion

DRUGELVORINE 100 mg/10 mL

DRUGsolution injectable

DRUGFLUOROURACILE ACCORD 50 mg/ml

DRUGXeloda 150 mg film-coated tablets

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
the success of a full curative therapeutic	—

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026